Week Ending November 17th, 2023
Biotech: 2 Transactions (1 PIPE and 1 RD ) totaling just over $200 Million
Med Tech: No Current Week Transactions
2023 YTD
159 Biotech transactions totaling just under $24 Billion v. 2022: 144 Biotech transactions totaling just under $18 Billion
18 Med Tech transactions totaling just over $1 Billion v. 2022: 10 Med Tech transactions just under $900 Million
Private Transactions:
Biotech: 220 Transactions / 67 European Transactions
Med Tech: 126 US Transactions / 37 European Transactions
November Major Transactions:
Astellas Pharma acquired Proprella Therapeutics - $175M
Ajinomoto acquired Forge Biologics - $554M
October Major Transactions:
Roche aqcuired Telavant - $7.1B
Bristol Myers Squibb aquired Mirati Therapeutics - $4.8B; $58/Share
AbbVie acquired Mitokinin - $110M
Kyowa Kirin acquired Orchard Therapeutics - $387M; $16/Share
Eli Lilly acquired Point Biopharma - $1.4B; $12.50/Share
Comentários